Healthcare -
Biotechnology - NASDAQ - GB
$ 0.5397
-0.0556 %
$ 23 M
Market Cap
-3.17
P/E
ADAP - CAPITAL EXPENDITURES
Capital Expenditures ADAP - Adaptimmune Therapeutics plc
-4.88 M
LAST VALUE
25.45%
2 YEAR CAGR
-0.72%
5 YEAR CAGR
-40.78%
10 YEAR CAGR